We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

Stock Unlock
Search global stocks & ETFs...Ctrl K
Learn Mode
BONEX.ST logo
Bonesupport Holding ABBONEX.ST
SEK 205.10
-SEK 14.30 (-6.518%)
3:25 PM
4.14/5
General
Scores
Financials & KPIs
Dividends
Analyst
Insider
Updates
BONEX.ST
(ST stock price quotes are delayed, fully updated by EOD)
Stock Profile
Market Cap
SEK 14.45B
Industry
Biotechnology
EPS (TTM)
SEK 2.78
P/E (TTM)
78.06
Div & Yield
--
FCF Payout Ratio
--
P/S (TTM)
11.89
P/B
15.39
Revenue Growth (TTM)
21.78%
EPS CAGR (3Y)
0.00%
Diluted Shares
66.77M
Ex-Dividend
--
Next Earnings
07-16
Forward P/E
--
Payout Ratio
--
P/FCF (TTM)
59.10
FCF Yield
1.69%
Earnings Yield
1.28%
Revenue CAGR (3Y)
47.03%
Recommended Metric
Score Card
Explore Scores Tab
4.14
Good
Bonesupport Holding AB has grown revenue at 21.78% over the past year, which is strong growth. Also, it has more cash than liabilities meaning it could use its current cash position to be completely debt-free, if it wanted to.
Valuation Score
Key Score
4.00
Good
Management
4.00
Good
Growth
4.00
Good
Profitability
5.00
Very Good
Fin. Health
5.00
Very Good
Dividends
--
--
Analyst
3.00
Average
Financials
Explore Financial Tab ›
Revenue
Earnings
Free Cash Flow
Insider Transactions
Explore Insider Tab ›
Buy Transactions
Sell Transactions
Peers
Select stocks to compare
BIOA B.ST logo
BIOA B.STBioarctic Ab
SEK 308.52
-0.35%
VICO.ST logo
VICO.STVicore Pharma Holding Ab
SEK 11.50
-0.86%
CR
CRNO B.STCereno Scientific Ab
SEK 4.54--
EGTX.ST logo
EGTX.STEgetis Therapeutics Ab (publ)
SEK 6.26
-0.32%
BIOG B.ST logo
BIOG B.STBiogaia Ab
SEK 115.50
-0.77%
HNSA.ST logo
HNSA.STHansa Biopharma Ab
SEK 33.40
+0.97%
VITR.ST logo
VITR.STVitrolife Ab
SEK 94.95
+8.76%
BINV.ST logo
BINV.STBioinvent International Ab
SEK 23.00
+0.44%
MVIR.ST logo
MVIR.STMedivir Ab
SEK 1.77--
SOBI.ST logo
SOBI.STSwedish Orphan Biovitrum Ab (publ)
SEK 472.00
+3.51%
Price Targets & Ratings
View Analysis
1-year price targets, ending Jun 28, 2027
Current
SEK 205.10
Baseline
High
SEK 436.80
▲
112.97%
Avg
SEK 379.27
▲
84.92%
Low
SEK 323.20
▲
57.58%
Analyst Ratings based on 13 Analysts
Strong Buy
5
38%
Buy
7
54%
Hold
1
08%
Sell
0
00%
Strong Sell
0
00%
About
Website
Address
BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. The company develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.Read More
IPO Date
2017-06-21
Industry
Biotechnology
Total Employees
160
Exchange
Nasdaq Omx Nordic
Reporting Currency
SEK
GICS
Biotechnology
GICS Sub
Biotechnology
GICS Sector
Health Care
GICS Group
Pharmaceuticals, Biotechnology & Life Sciences
Stock News
View All Updates